ArticleCell death and differentiation2026

KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition.

Nana Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.